About Abliva
Abliva is a company based in Lund (Sweden) founded in 2000 was acquired by Pharming Group in February 2025.. Abliva offers products and services including KL1333 and NV354. Abliva operates in a competitive market with competitors including Nura Bio, Healx, Cingulate, STALICLA and PaxMedica, among others.
- Headquarter Lund, Sweden
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abliva, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$20.45 M (USD), Post-IPO
Jun 03, 2022
-
Investors
Pharming Group
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Pharming Group
(Feb 10, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abliva
Abliva offers a comprehensive portfolio of products and services, including KL1333 and NV354. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug candidate for treating primary mitochondrial diseases.
Potential treatment for mitochondrial disease symptoms.
Unlock access to complete
Unlock access to complete
Funding Insights of Abliva
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $20.4M
-
First Round
First Round
(11 Mar 2019)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Post-IPO - Abliva | Valuation |
investors |
|
| Mar, 2019 | Amount | Post-IPO - Abliva | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Abliva
Abliva has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Pharming Group, IP Group and Hadean Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and advisory services are offered across multiple sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Offers pension schemes, insurance products, and loans through employer-based programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Abliva
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Abliva
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abliva Comparisons
Competitors of Abliva
Abliva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nura Bio, Healx, Cingulate, STALICLA and PaxMedica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic solutions and neuroprotective medicines for neurological disorders are provided.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for rare diseases is developed.
|
|
| domain | founded_year | HQ Location |
Cingulate is focused on developing treatments for ADHD and anxiety.
|
|
| domain | founded_year | HQ Location |
Precision medicines for neurodevelopmental disorders are manufactured using DEPI technology.
|
|
| domain | founded_year | HQ Location |
Drugs for neurodevelopmental disorders are developed by PaxMedica.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abliva
Frequently Asked Questions about Abliva
When was Abliva founded?
Abliva was founded in 2000 and raised its 1st funding round 19 years after it was founded.
Where is Abliva located?
Abliva is headquartered in Lund, Sweden.
What does Abliva do?
Abliva was founded in 2000 in Lund, Sweden, within the biotechnology sector focused on neurological treatments. Drug candidates such as KL1333, an NAD regulator, are advanced for chronic primary mitochondrial diseases including MELAS-MIDD and PEO-KSS spectrum disorders. NVP025 is targeted at mitochondrial myopathies, while NeuroSTAT addresses traumatic brain injury. Additional candidates like NV354 are under development for related conditions.
Who are the top competitors of Abliva?
What products or services does Abliva offer?
Abliva offers KL1333 and NV354.
Who are Abliva's investors?
Abliva has 5 investors. Key investors include Pharming Group, IP Group, Hadean Ventures, Oslo Pensjonsforsikring, and NYIP.